Release date: 2015-12-02 Medtronic's MICRA transcatheter pacing system and hybrid closed-loop insulin infusion system (including an insulin pump and continuous blood glucose monitor) won the "BEST OF WHAT'S NEW 2015" from the authoritative technology magazine "New Age of Technology". A total of 100 innovative technologies were selected, including 12 medical health categories. Medtronic is honored to have 2 technologies among them. These innovative technologies represent a huge step forward in the development of technology in their respective fields and will be presented in more detail in the December issue of the magazine. Cliff Ransom, editor-in-chief of the New Age of Technology magazine, said, "BEST OF WHAT'S NEW is designed to recognize technological innovations that challenge the future, and is the magazine's highest award. Hundreds of award-winning technologies stand out in their respective fields. Revolutionary change." Source: Medtronic Uv Spot Curing Light,Uv Spot Lamp,Uv Spot Curing,Uv Curing Spot Lamp Rolence Enterprise Inc. , https://www.rolencedent.com
The wire-free cardiac pacemaker Micra TPS is less than one-tenth the size of a conventional pacemaker, with advanced pacing technology and small enough to be implanted into the heart via minimally invasive techniques. abnormal. The Micra TPS is like a large vitamin capsule that can be used for pacing without the need for an electrode lead and can be implanted in the right ventricle with small claws. Micra TPS is still in the clinical stage in the United States and has not yet been approved for marketing. In April 2015, Micra TPS received EU CE certification and is compatible with 1.5T and 3T full-body MRI nuclear magnetic scans, allowing patients to receive advanced imaging scans with confidence.
Thanks to the epoch-making technological advancement of the Medtronic MiniMed 640G system [1], the hybrid closed-loop insulin infusion system automatically controls blood glucose levels in diabetic patients 24 hours a day, reducing human intervention. When using the system, the patient only needs to enter the carbohydrate value during the meal and regularly calibrate the probe, which greatly reduces the workload of the diabetic patient for one day. The hybrid closed-loop insulin infusion system is undergoing clinical trials and has not been put into clinical use. The first closed-loop technology critical clinical trial of this technology is being conducted in the United States. As the largest and longest-running daily environmental closed-loop clinical trial in Medtronic, this one-arm, multi-center, and daily environmental clinical trial will be enrolled in patients with type 1 diabetes (14 to 75 years old) who are using insulin pump therapy. 150 people. For more information on clinical trials, please visit ClinicalTrials. Gov (item number: NCT02463097).
Medtronic's two innovations ranked in the list of 12 major medical new technologies in 2015